IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4587
Positioning
Market Dominance
Manufacturing
Electronic Equipment
$373M
Sumit Sharma
MicroVision, Inc. develops lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems, laser diodes, opto-mechanics, electronics, algorithms, and software. The company also develops micro-display concepts and designs for head-mounted augmented reality headsets.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$MVIS MICROVISION, INC. | 29 | 25 | 39 | 20 | - | - | -80.2% | -48.2% | -214.8% | -6346.0% | -7033.0% | -87.3% | 0.0% | 32.0x | $373M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
MICROVISION, INC. (MVIS) receives a "Avoid" rating with a composite score of 29.0/100. It ranks #4587 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Sumit Sharma
Chief Executive Officer
Labor Force
350
25
25
30
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for MVIS
Lagging peers — losers tend to keep underperforming
Fair valuation relative to peers
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for MVIS.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
ROE proxy -80.2% (sector -2.5%)
GM -215% vs sector 43%, OM -6346% vs sector 1%
Capital turnover N/A, R&D intensity 2339.0%
Rev growth -87%, 10yr history
Interest coverage -5.8x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags MICROVISION, INC. with an Avoid rating, assigning a composite score of 29.0/100 and 1 out of 5 stars. Ranked #4587 of 7,333 stocks, MVIS falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
MVIS's quality score of 25/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -80.2% (sector avg: -2.5%), gross margins of -214.8% (sector avg: 42.5%), net margins of -7033.0% (sector avg: -0.2%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
With a value score of 39/100, MVIS appears somewhat expensive relative to its fundamentals. Key valuation metrics include a P/B ratio of 2.86x. Investors paying a premium here are likely betting on above-average growth or margin expansion to justify current prices.
MICROVISION, INC.'s investment score of 25/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -87.3% vs. a sector average of 5.9% and a return on assets of -48.2% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
MICROVISION, INC. is experiencing notably weak momentum with a score of just 20/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at -87.3% year-over-year, while a beta of 1.78 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
MVIS's stability score of 30/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 1.78 and a debt-to-equity ratio of 32.00x (sector avg: 0.2x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
MICROVISION, INC.'s short interest score of 24/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include high market sensitivity (beta: 1.78), elevated leverage (D/E: 32.00x), small-cap liquidity risk. At $373M (small-cap), MVIS carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
MICROVISION, INC. is a small-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #4587 of 7,333 overall (37th percentile). Key comparisons include ROE of -80.2% trailing the -2.5% sector median and operating margins of -6346.0% below the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While MVIS currently exhibits a AVOID profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Momentum (20) would have the largest impact on the composite score.
ROE 3133% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 605% BELOW SECTOR MEDIAN
Op. Margin 492036% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate MICROVISION, INC. (MVIS) as Avoid with a composite score of 29.0/100 at a current price of $0.88. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in value (39th percentile) and stability (30th percentile), which together account for the majority of the composite score. Offsetting weakness in momentum (20th percentile) and quality (25th percentile) tempers our overall conviction. We assign a No Moat rating (18/100), Very High uncertainty, and Poor capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
MICROVISION, INC. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 29.0/100 places it at rank #4587 in our full 7,333-stock universe. At $373M in market capitalization, MICROVISION, INC. is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue contraction of -87% combined with momentum at the 20th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
The margin cascade tells an important story: gross margins of -215% (-257.3pp vs sector) narrow to operating margins of -6346% (-6347.3pp vs sector) and net margins of -7033.0%, yielding a gross-to-net conversion rate of N/A%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $0.88, MICROVISION, INC. is trading at a premium to fundamental value. Our value factor score of 39/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at P/B of 2.9x, P/S of 220.9x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
The stock may offer contrarian value if near-term headwinds prove transitory — the current weakness in factor scores may reverse if business fundamentals stabilize.
The Avoid rating (composite 29.0/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Revenue decline of -87% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Thin net margins of -7033.0% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Weak momentum (20th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
We assign a Very High uncertainty rating to MICROVISION, INC.. The stock exhibits multiple compounding risk factors: elevated market sensitivity (beta of 1.78), current negative profitability (net margin -7033.0%), below-average price stability (30th percentile). The extreme uncertainty around future cash flows makes precise valuation difficult, and the range of outcomes is exceptionally wide. Only investors with high risk tolerance and extended time horizons should consider this name.
Specific risk factors that inform our assessment include: elevated market sensitivity (beta of 1.78); current negative profitability (net margin -7033.0%); below-average price stability (30th percentile); weak quality scores (25th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 30th percentile and quality factor at the 25th percentile provide a quantitative summary of the overall risk landscape.
We identify limited risk mitigants at this time, which contributes to our very high uncertainty assessment. Investors should monitor for improvement in balance sheet metrics, margin stability, and business predictability that could warrant a downgrade in our risk assessment over time.
We rate MICROVISION, INC.'s capital allocation as Poor. Key concerns include low returns on equity (-80.2%), negative profitability, weak asset returns (ROA -48.2%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — MICROVISION, INC. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, MICROVISION, INC. receives a Avoid rating with a composite score of 29.0/100 (rank #4587 of 7,333). Our quantitative framework assigns a No Moat (18/100, trend: stable), Very High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 28/100.
Our analysis does not support a constructive view on MICROVISION, INC. at this time. The combination of limited competitive advantages, very high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign MICROVISION, INC. a meaningful economic moat, scoring 18/100 on our composite assessment. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, reinvestment efficiency, reached only 7/20.
The strongest moat sources are reinvestment efficiency (7/20) and financial resilience (5.9/20). Capital turnover N/A, R&D intensity 2339.0%. Interest coverage -5.8x. These pillars form the core of MICROVISION, INC.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include margin superiority (0/20) and growth durability (2.1/20). GM -215% vs sector 43%, OM -6346% vs sector 1%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect MICROVISION, INC.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include declining revenues (-87%) that pressure the earnings outlook. The margin cascade from -215% gross to -6346% operating to -7033.0% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 25th percentile.
The margin profile shows gross margins of -215%, operating margins of -6346%, net margins of -7033.0%. Return metrics include ROE of -80.2% and ROA of -48.2%. Relative to the Manufacturing sector, gross margins are 257.3 percentage points below the sector median of 43%, and ROE of -80.2% compares to a sector median of -2.5%.
The balance sheet reflects moderate leverage with D/E of 32%, revenue growth of -87%. The sector median D/E is 0%, putting MICROVISION, INC. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Below-average quality (25th percentile) raises durability concerns about the fundamental profile and increases the risk of negative earnings surprises.
Above 50MA
37.18%
Net New Highs
+51081
REDMOND, WA / ACCESS Newswire / February 24, 2026 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced a video-enabled business update and fireside chat on February ...
REDMOND, WA / ACCESS Newswire / February 24, 2026 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced that it had enhanced its financial position by issuing senior ...
MicroVision (NasdaqGM:MVIS) has agreed to acquire key assets from Luminar Technologies through a Section 363 bankruptcy sale process. The package includes intellectual property, critical inventory, engineering staff, and existing commercial contracts, subject to bankruptcy court approval. The transaction is tied to Luminar's ongoing bankruptcy proceedings and remains contingent on court and procedural milestones. MicroVision focuses on lidar sensors and advanced perception solutions for...

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. Decibel Therapeutics, Inc. (NASDAQ: DBTX) gained 76% to $4.9150 after Regeneron announced it will acquire the company. Benitec Biopharma Inc. (NASDAQ: BNTC) jumped 75.8% to $3.3937. Benitec Biopharma reported pricing of $30 million underwritten public offering. Renovaro Biosciences Inc. (NASDAQ: RENB) shares gained 68.2% to $1.43 after the company and AI-focused GEDi Cube announced a binding, exclusive letter of intent to merge. T Stamp Inc. (NASDAQ: IDAI) climbed 48.8% to $2.3518. EBET, Inc. (NASDAQ: EBET) surged 40.5% to $0.0405 on abnormally-high volume. The stock was set to be suspended at the opening of business today unless the company requested an appeal of Nasdaq's Listing Qualifications Department's determination. Millennium Group International Holdings Limited (NASDAQ: MGIH) gained 40% to $2.7003 on strong volume. Science 37 Holdings, Inc. (NASDAQ: SNCE) jumped 39.3% to $0.3765 following better-than-expected quarterly results. BioNexus Gene Lab Corp. (NASDAQ: BGLC) gained 36.5% to $1.5699. Kubient, Inc. (NASDAQ: KBNT) rose 33.7% to $0.63. Oportun Financial Corporation (NASDAQ: OPRT) gained 31.3% to $6.90 following strong quarterly results. Poseida Therapeutics, Inc. (NASDAQ: PSTX) climbed 31.3% to $2.60 following quarterly results. Mirati Therapeutics, Inc. (NASDAQ: MRTX) surged 30.1% to $36.17 after the company reported second-quarter financial results. Also, B. Riley Securities upgraded the stock from Neutral to Buy and announced a $45 price target. Allbirds, Inc. (NASDAQ: BIRD) gained 29% to $1.65 after the company reported better-than-expected second-quarter financial results. Array Technologies, Inc. (NASDAQ: ARRY) climbed 27.8% to $22.85 following a second-quarter earnings beat. Computer Task Group, Incorporated (NASDAQ: CTG) gained 27.8% to $10.23 after the company announced it will be acquired by Cegeka for $10.50 per share. LivePerson, Inc. (NASDAQ: LPSN) rose 27.5% to $5.09 r after the company announced a second-quarter earnings beat. The company named John Collins as the Interim CEO. PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) gained 22.3% to $8.31 after the company reported better-than-expected second-quarter EPS results. Celsius Holdings, Inc. (NASDAQ: CELH) jumped 21.8% to $174.73 after the company reported better-than-expected second-quarter financial results. United Insurance Holdings Corp. (NASDAQ: UIHC) gained 21.3% to $6.83. DMC Global Inc. (NASDAQ: BOOM) climbed 19.8% to $21.03 following quarterly results. Dutch Bros Inc. (NYSE: BROS) surged 19.8% to $33.55 after the company reported better-than-expected quarterly EPS results and issued FY23 guidance. Azenta, Inc. (NASDAQ: AZTA) gained 19.6% to $57.45 fter the company reported better-than-expected third-quarter financial results and issued fourth-quarter EPS guidance above estimates. Additionally, Needham raised its price target from $55 to $65 on the stock. ThredUp Inc. (NASDAQ: TDUP) climbed 19.5% to $3.85 after the company reported better-than-expected second-quarter financial results and issued revenue guidance. Also, Goldman Sachs raised its price target from $3 to $4 on the stock. Planet Green Holdings Corp. (NASDAQ: PLAG) rose 17.5% to $0.5670. Anavex Life Sciences Corp. (NASDAQ: AVXL) climbed 16.2% to $ 9.33. Rapid7, ...

U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. Doximity, Inc. (NYSE: DOCS) shares dipped 24.4% to $24.80 in pre-market trading after the company issued weak sales forecast. PubMatic, Inc. (NASDAQ: PUBM) shares tumbled 18% to $15.22 in pre-market trading after the company issued weak third-quarter revenue guidance. AerSale Corporation (NASDAQ: ASLE) declined 17.8% to $12.00 in pre-market after the company reported downbeat second-quarter results and issued weak 2023 sales outlook. Upstart Holdings, Inc. (NASDAQ: UPST) tumbled 17.4% to $42.73 in pre-market trading. Upstart reported better-than-expected results for its second quarter, but issued weak revenue forecast for the third quarter. 2U, Inc. (NASDAQ: ...